Združene države Amerike - angleščina - myHealthbox

ecolab -

Združene države Amerike - angleščina - myHealthbox

bayer ag -

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - chloropicrin; 1,3-dichloropropene - liquid - chloropicrin gas active 333.0 g/kg; 1,3-dichloropropene solvent active 608.0 g/kg - mixed function pesticide - field crop | fruit crop | nursery crop | nut crop | vegetable crop | nursery plant - fusarium crown rot or wilt | nematode - soil borne plant parasitic | pythium spp. | rhizoctonia | soil borne diseases | suppression of annual grass weeds | symphylid | verticillium wilt | wireworm | garden centipedes | grease spot | pythium blight | soil fungi | symphylans | verticillium dahliae | verticillium soil fungus

Avstralija - angleščina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

trical australia pty ltd - chloropicrin; 1,3-dichloropropene - liquid - chloropicrin gas active 595.0 g/kg; 1,3-dichloropropene solvent active 380.0 g/kg - mixed function pesticide - field crop | fruit crop | nursery crop | nut crop | strawberry | vegetable crop | nursery plant - nematode - soil borne plant parasitic | soil borne diseases | suppression of annual grass weeds | symphylid | wireworm | garden centipedes | symphylans

Združene države Amerike - angleščina - NLM (National Library of Medicine)

sti pharma - ethambutol hydrochloride (unii: qe4vw5fo07) (ethambutol - unii:8g167061qz) - ethambutol hydrochloride 400 mg - ethambutol hci is indicated for the treatment of pulmonary tuberculosis. it should not be used as the sole antituberculous drug, but should be used in conjunction with at least one other antituberculous drug. selection of the companion drug should be based on clinical experience, considerations of comparative safety, and appropriate in vitro susceptibility studies. in patients who have not received previous antituberculous therapy, ie, initial treatment, the most frequently used regimens have been the following: in patients who have received previous antituberculous therapy, mycobacterial resistance to other drugs used in initial therapy is frequent. consequently, in such retreatment patients, ethambutol hci should be combined with at least one of the second line drugs not previously administered to the patient and to which bacterial susceptibility has been indicated by appropriate in vitro studies. antituberculous drugs used with ethambutol hci have included cycloserine, ethionamide, pyrazinamide, viomycin a

Združene države Amerike - angleščina - NLM (National Library of Medicine)

proficient rx lp - cyproheptadine hydrochloride (unii: nj82j0f8qc) (cyproheptadine - unii:2yhb6175do) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema. amelioration of allergic reactions to blood or plasma cold urticaria dermatographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. hypersensitivity to cyproheptadine and other drugs of similar chemical structure. monoamine oxidase inhibitor therapy (see drug interactions .) angle-closure glaucoma stenosing peptic ulcer symptomatic prostatic hypertrophy bladder neck obstruction pyloroduodenal obstruction elderly, debilitated patients

Združene države Amerike - angleščina - NLM (National Library of Medicine)

golden state medical supply - cyproheptadine hydrochloride (unii: nj82j0f8qc) (cyproheptadine - unii:2yhb6175do) - perennial and seasonal allergic rhinitis vasomotor rhinitis allergic conjunctivitis due to inhalant allergens and foods mild, uncomplicated allergic skin manifestations of urticaria and angioedema. amelioration of allergic reactions to blood or plasma cold urticaria dermatographism as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing mothers. hypersensitivity to cyproheptadine and other drugs of similar chemical structure. monoamine oxidase inhibitor therapy (see drug interactions .) angle-closure glaucoma stenosing peptic ulcer symptomatic prostatic hypertrophy bladder neck obstruction pyloroduodenal obstruction elderly, debilitated patients

Združene države Amerike - angleščina - NLM (National Library of Medicine)

nucare pharmaceuticals,inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 25 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of cortico steroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Združene države Amerike - angleščina - NLM (National Library of Medicine)

cosette pharmaceuticals, inc. - desonide (unii: j280872d1o) (desonide - unii:j280872d1o) - desonide 0.5 mg in 1 g - desonide cream, 0.05% is a low potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses. it should not be used for longer than two weeks unless directed by a physician. desonide cream, 0.5% is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation. safety and effectiveness in pediatric patients have not been established. because of a higher ratio of skin surface area to body mass, pediatric patients are at a greater risk than adults of hpa axis suppression and cushing’s syndrome when they are treated with topical corticosteroids. they are therefore also at greater risk of adrenal insufficiency during or after withdrawal of treatment. adverse effects including striae have been reported with inappropriate use of topical corticosteroids in infants and children. hpa axis suppression, cushing’s syndrome, linear growth retardation

Združene države Amerike - angleščina - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - fluocinonide (unii: 2w4a77ypan) (fluocinonide - unii:2w4a77ypan) - fluocinonide cream usp, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. fluocinonide cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.